Description of Event or Problem · 1
PATIENT IMPLANTED WITH BIOLOGIC INFUSE RHBMP-2 USED IN COMBINATION WITH MODULAR VERTE-STACK ANATOMIC PEEK COMPONENTS FOR C5 SINGLE-LEVEL CERVICAL VERTEBRAL BODY REPLACEMENT (CORPECTOMY) AND C4-5/C5-6 ANTERIOR CERVICAL DISCECTOMY AND FUSION. PATIENT WAS NOT INFORMED OF 2008 FDA PUBLIC NOTICE WARNING OF LIFE-THREATENING COMPLICATIONS REFERENCING USE OF RHBMP-2 IN THE CERVICAL SPINE, NOR WAS PATIENT INFORMED THAT USE OF THE VERTE-STACK COMPONENTS IN THE CERVICAL SPINE IS CONTRAINDICATED ON THE DEVICE LABELING CLEARED BY THE FDA [K070173]. HTTPS://WEB.ARCHIVE.ORG/WEB/20160801140944/HTTPS://WWW.FDA.GOV/CDRH/510K/K070173.PDF. STUDIES SHOW RHBMP-2 EXPRESSION ASSOCIATED WITH METASTATIC PROSTATE CANCER PATIENTS [HTTPS://WWW.NCBI.NLM.NIH.GOV/PUBMED/2130271]. IN (B)(6) 2020, PATIENT WAS DIAGNOSED WITH METASTATIC PROSTATIC CANCER EXTRACAPSULAR INVOLVEMENT THROUGH PSA VELOCITY, MRI, FUSION BIOPSY AND HISTOLOGY. FDA SAFETY REPORT ID# (B)(4).